| Members |
targetComponentId |
| Adverse reaction to clomocycline sodium |
Adverse reaction to clomocycline |
| Adverse reaction to clorazepate dipotassium |
Adverse reaction to clorazepate |
| biverkning av vaccin mot SARS-CoV-2 |
Adverse reaction to COVID-19 vaccine |
| Adverse reaction to sodium cromoglycate |
Adverse reaction to cromoglicic acid |
| Adverse reaction to sodium fusidate |
Fusidic acid adverse reaction |
| Aerobacter aerogenes gastrointestinal tract infection |
Gastrointestinal infection caused by Klebsiella aerogenes |
| Aerobacter meningitis |
Meningitis caused by Klebsiella aerogenes |
| Aeromonas aquariorum |
Aeromonas dhakensis |
| Aeromonas enteropelogenes |
Aeromonas trota |
| Aeromonas tructi |
Aeromonas trota |
| Aerosol or vapor inhalation for bronchodilation |
Inhaled bronchodilator therapy |
| Affect finding |
Mood finding |
| Afipia felis |
Afipia felis |
| Agammaglobulinemia |
Congenital agammaglobulinemia |
| Agrobacterium radiobacter |
Rhizobium radiobacter (organism) |
| Agrobacterium tumefaciens |
Rhizobium radiobacter (organism) |
| shunt med Ahmedventil |
Valved ophthalmic drainage device (physical object) |
| Air |
Air |
| Albright hereditary osteodystrophy |
Pseudohypoparathyroidism |
| Albumin human + epoetin alfa 2.5mg/20000unt injection |
Epoetin alfa 20000 unit/mL solution for injection |
| humant albumin 2,5 mg + epoetin alfa 20 000 IE injektionsvätska, lösning, flaska |
Epoetin alfa 20000 unit/mL solution for injection |
| salbutamol 0,0417 %, lösning för inhalation |
Salbutamol sulfate 417 microgram/mL solution for inhalation |
| salbutamol 200 mikrogram, kapsel |
Salbutamol 200 microgram/actuation powder for inhalation |
| salbutamol 90 mikrogram per inhalation, aerosol |
Product containing only salbutamol in pulmonary dose form (medicinal product form) |
| Albuterol sulfate + ipratropium bromide |
Product containing ipratropium and salbutamol (medicinal product) |
| Albuterol sulfate + ipratropium bromide 103mcg/18mcg |
Ipratropium and salbutamol only product in pulmonary dose form |
| salbutamolsulfat 103 mikrogram + ipratropiumbromid 18 mikrogram, aerosol |
Ipratropium and salbutamol only product in pulmonary dose form |
| Albuterol sulfate 4mg tablet |
Salbutamol (as salbutamol sulfate) 4 mg oral tablet |
| Albuterol+ipratropium bromide |
Product containing ipratropium and salbutamol (medicinal product) |
| Alcaligenes aeutus |
Halomonas aquamarina |
| Alcaligenes aquamarinus |
Halomonas aquamarina |
| Alcaligenes defragrans |
Castellaniella defragrans (organism) |
| Alcaligenes eutrophus |
Wautersia eutropha (organism) |
| Alcaligenes fecalis ss. homari |
Halomonas aquamarina |
| Alcaligenes paradoxus |
Variovorax paradoxus |
| Alcaligenes xylosoxidans |
Achromobacter xylosoxidans (organism) |
| Alcaligenes xylosoxidans, underart xylosoxidans |
Achromobacter xylosoxidans (organism) |
| Alcaligenes xylosoxidans subsp xylosoxidans |
Achromobacter xylosoxidans (organism) |
| Alcohol-induced polyneuropathy |
Alcoholic polyneuropathy |
| alkoholhaltigt koltjäreextrakt 5 %, schampo |
Coal tar 50 mg/mL shampoo |
| allergi mot desinfektionsmedel innehållande aldehyd |
Allergy to aldehyde |
| Aldehyde-lyase |
Aldehyde-lyase (substance) |
| Alders syndrom |
Alder-Reilly body (finding) |
| aldesleukin 18 megaenheter, pulver till injektionsvätska, flaska |
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Alendronate sodium |
Product containing alendronic acid (medicinal product) |
| Alendronate sodium + cholecalciferol |
Product containing alendronic acid and colecalciferol (medicinal product) |
| Alendronate sodium 13.05mg tablet |
Product containing precisely alendronic acid (as alendronate sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| alendronatnatrium 70 mg/75 ml, oral lösning |
Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Aleukemic leukemia |
Leukaemia |
| Alexanderteknik |
Alexander technique (regime/therapy) |
| Alfalfa mosaic virus group (Plant hosts) |
Genus Alfamovirus (organism) |
| algodystrofi i fot |
Complex regional pain syndrome of foot (disorder) |
| algodystrofi i hand |
Complex regional pain syndrome of hand (disorder) |
| algodystrofi i knä |
Complex regional pain syndrome of knee (disorder) |
| främmande miljö |
Alien environment |
| Aliphatic carboxylic acid, C22-0 |
Behenic acid |
| Aliphatic carboxylic acid, C24-0 |
Lignoceric acid |
| alkalasspecifikt extrakt |
Product containing alkalase (medicinal product) |
| förgiftning orsakad av alkaliserande medel |
Poisoning |
| test av kognitiv prestation enligt Allen |
Cognitive Performance Test (assessment scale) |
| Allens test |
Allen test for arterial competency |
| allergisk neuropati |
Immune-mediated neuropathy |
| Allergic non-atopic asthma |
Asthma |
| allergisk reaktion mot kontrastmedel |
Non-allergic hypersensitivity reaction caused by radiocontrast media |
| allergisk reaktion mot sulfit |
Non-allergic hypersensitivity reaction caused by sulfite (disorder) |
| allergi- och immunologiverksamhet |
Allergy service |
| allergi mot angiotensin 2-receptorantagonist |
Non-allergic hypersensitivity to angiotensin II receptor antagonist (finding) |
| aspartamallergi |
Non-allergic hypersensitivity to aspartame (finding) |
| allergi mot medel mot tuberkulos innehållande hydrazid |
Allergy to isoniazid |
| allergi mot ytantigenvaccin mot influensa |
Allergy to influenza vaccine |
| allergi mot inhalationskortikosteroider |
Allergy to corticosteroid and/or corticosteroid derivative (finding) |
| allergi mot vaccin med meningokockpolysackarid |
Allergy to meningococcus vaccine |
| allergi mot prednisolon för oftalmiskt bruk |
Allergy to prednisolone |
| allergi mot sulfitbaserade konserveringsmedel |
Non-allergic hypersensitivity reaction caused by sulfite (disorder) |
| allergi mot vaccin med tyfoidpolysackarid |
Allergy to typhoid vaccine |
| allergi mot helcellsvaccin mot tyfoid |
Allergy to typhoid vaccine |
| Allo-cortolones |
Cortolone (substance) |
| Allo-cortols |
Cortol |
| Allograft |
Allograft |
| ersättning av fyra eller fler koronarartärer med allograft |
Allograft bypass of four or more coronary arteries (procedure) |
| ersättning av en koronarartär med allograft |
Allograft bypass of one coronary artery (procedure) |
| ersättning av tre koronarartärer med allograft |
Allograft bypass of three coronary arteries (procedure) |
| ersättning av två koronarartärer med allograft |
Allograft bypass of two coronary arteries (procedure) |
| Almoor-operation |
Drainage of petrous apex of mastoid |
| Alopex lagopus |
Vulpes lagopus (organism) |
| alfaamylasspecifikt extrakt |
Product containing alpha-amylase (medicinal product) |
| alfa-1-antitrypsin |
Human alpha1 proteinase inhibitor-containing product |
| Alphaherpesvirus group |
Subfamily Alphaherpesvirinae (organism) |
| alprostadil 10,16 mikrogram/ml, lösning |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| alprostadil 20,2 mikrogram/ml, lösning |
Alprostadil 20 microgram/mL solution for injection |
| alprostadil 40 mikrogram, cylinderampull, för injektion, upptrappningsförpackning |
Alprostadil only product in parenteral dose form |
| alprostadil 40 mikrogram, pulver och vätska till injektionslösning, cylinderampull |
Alprostadil only product in parenteral dose form |
| alprostadil 40 mikrogram, pulver till injektionsvätska, lösning, cylinderampull |
Alprostadil only product in parenteral dose form |
| alprostadil 500 mikrogram/ml, infusionskoncentrat, ampull 1 ml |
Alprostadil 500 microgram/mL solution for injection |
| Alteration in cardiac output: decreased |
Decreased cardiac output |
| aluminiumacetat 13 %, örondroppar |
Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) |
| aluminiumacetat 8 %, örondroppar |
Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) |
| Aluminum hydroxide (in vaccine) |
Aluminium hydroxide |
| aluminiumbaserat antacidum |
Aluminum compound |
| Alverine citrate+sterculia |
Alverine- and Sterculia gum-containing product |
| Amantadine hydrochloride [anti viral] |
Product containing amantadine (medicinal product) |
FHIR